Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Senft

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
The Journal of Clinical Investigation|July 22, 2009
Proapoptotic signaling induced by RIG-I and MDA-5 results in type I interferon-independent apoptosis in human melanoma cellsRobert Besch, Hendrik Poeck, Tobias Hohenauer, et al.
Haematologica|December 1, 2020
Plasticity in growth behavior of patients' acute myeloid leukemia stem cells growing in miceSarah Ebinger, Christina Zeller, Michela Carlet, et al.
EMBO Molecular Medicine|November 23, 2022
X-linked inhibitor of apoptosis protein represents a promising therapeutic target for relapsed/refractory ALLMichela Carlet, Karin Schmelz, Jenny Vergalli, et al.
EMBO Molecular Medicine|May 14, 2013
The neural crest transcription factor Brn3a is expressed in melanoma and required for cell cycle progression and survivalTobias Hohenauer, Carola Berking, Andreas Schmidt, et al.
Leukemia|November 5, 2022
In vivo PDX CRISPR/Cas9 screens reveal mutual therapeutic targets to overcome heterogeneous acquired chemo-resistanceAnna-Katharina Wirth, Lucas Wange, Sebastian Vosberg, et al.
Nature Communications|September 28, 2021
In vivo inducible reverse genetics in patients' tumors to identify individual therapeutic targetsMichela Carlet, Kerstin Völse, Jenny Vergalli, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
The Journal of Clinical Investigation|July 22, 2009
Proapoptotic signaling induced by RIG-I and MDA-5 results in type I interferon-independent apoptosis in human melanoma cellsRobert Besch, Hendrik Poeck, Tobias Hohenauer, et al.
Haematologica|December 1, 2020
Plasticity in growth behavior of patients' acute myeloid leukemia stem cells growing in miceSarah Ebinger, Christina Zeller, Michela Carlet, et al.
EMBO Molecular Medicine|November 23, 2022
X-linked inhibitor of apoptosis protein represents a promising therapeutic target for relapsed/refractory ALLMichela Carlet, Karin Schmelz, Jenny Vergalli, et al.
EMBO Molecular Medicine|May 14, 2013
The neural crest transcription factor Brn3a is expressed in melanoma and required for cell cycle progression and survivalTobias Hohenauer, Carola Berking, Andreas Schmidt, et al.
Leukemia|November 5, 2022
In vivo PDX CRISPR/Cas9 screens reveal mutual therapeutic targets to overcome heterogeneous acquired chemo-resistanceAnna-Katharina Wirth, Lucas Wange, Sebastian Vosberg, et al.
Nature Communications|September 28, 2021
In vivo inducible reverse genetics in patients' tumors to identify individual therapeutic targetsMichela Carlet, Kerstin Völse, Jenny Vergalli, et al.
Pageof 7